Details of the Drug

General Information of Drug (ID: DM2CLXU)

• Drug Name: M207

Indication

Disease Entry	ICD 11	Status	REF
Migraine	8A80	Phase 3	[1]

• Cross-matching ID: TTD ID: D0K5ET

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)